Effects of nitric oxide scavenger, carboxy-PTIO on endotoxin-induced alterations in systemic hemodynamics in rats

Japanese Journal of Pharmacology

Volumn 82, Issue 3, 2000, Pages 261-264

  Miura, Katsuyuki ^a   Yamanaka, Shinya ^a   Ebara, Tsuneyuki ^a   Okumura, Michiaki ^a   Imanishi, Masahito ^a   Kim, Shokei ^a   Nakatani, Tatsuya ^b   Iwao, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Carboxy PTIO; Endotoxic shock; Nitric oxide

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; NITRIC OXIDE; SCAVENGER;

ANIMAL MODEL; ARTERY TONE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG MECHANISM; HEART OUTPUT; HEART RATE; HEMATOCRIT; HEMODYNAMICS; HYPOTENSION; NONHUMAN; RAT; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE;

EID: 0034128456     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.261     Document Type: Article

References (15)

1. Szabo C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 3, 2-32 (1995)
2. Mulder MF, van Lambalgen AA, Huisman E, Visser JJ, van den Bos GC and Thijs LG: Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 266, H1558-H1564 (1994)
3. Fishman D, Liaudet L, Lazor R, Perret CH and Feihl F: L Canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit Care Med 25, 469-475 (1997)
4. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H and Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide. Cell 81, 641-650 (1995)
5. Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S and Maeda H: Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 202, 923-930 (1994)
6. Ebara T, Miura K, Matsuura T, Imanishi M, Yamano Y, Kim S and Iwao H: Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock. Jpn J Pharmacol 71, 247-253 (1996)
7. Hare JM, Keaney JF Jr, Balligand JL, Loscalzo J, Smith TW and Colucci WS: Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest 95, 360-366 (1995)
8. Yamanaka S, Iwao H, Yukimura T, Kim S and Miura K: Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. Br J Pharmacol 110, 1501-1507 (1993)
9. G-nitro-L-arginine on effective vascular stiffness in dogs. Jpn J Pharmacol 63, 41-45 (1993)
10. Booke M, Meyer J, Lingnau W, Hinder F, Traber LD and Traber DL: Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horiz 3, 123-138 (1995)
11. Petros A, Bennett D and Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338, 1557-1558 (1991)
12. Wu CC, Chen SJ, Szabo C, Thiemermann C and Vane JR: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114, 1666-1672 (1995)
13. Hock CE, Yin K, Yue G and Wong P: Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am J Physiol 272, H843-H850 (1997)
14. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJ and Moncada S: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110, 1189-1195 (1993)
15. Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S and Maeda H: Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/-NO through a radical reaction. Biochemistry 32, 827-832 (1993)